SPI1 and systemic sclerosis: In the skin fibroblasts of patients with systemic sclerosis, knocking out the PU.1 gene can down‐regulate α‐SMA expression, and knocking out PU.1 in mouse fibroblasts can alleviate fibrosis in the liver and skin of model animals.16